Home
Featured Story
April 1, 2024
Eminent cancer physician-scientist joins Virginia Tech to lead research in Washington, D.C.
A globally recognized physician-scientist who studies and treats blood cancer is joining Virginia Tech to lead cancer research in Washington, D.C., said Michael Friedlander, Virginia Tech’s vice president for health sciences and technology and executive director of the Fralin Biomedical Research Institute at VTC. Christopher Hourigan, a senior investigator and chief of the Laboratory of Myeloid Malignancies at the National Institutes of Health, will join Virginia Tech as a professor with the institute and director of its Cancer Research Center in Washington, D.C.
“Dr. Hourigan exemplifies the prototype of a physician-scientist, integrating insights from his patient interactions directly into his fundamental and translational laboratory research,” Friedlander said. “We are extremely enthusiastic to have him join Virginia Tech and become a member of the Fralin Biomedical Research Institute team to take on this important new leadership role for our growing cancer research programs in Washington, D.C., and to further strengthen our collaborations with Carilion Clinic, Children’s National Hospital, and other health systems and universities.
Campus News
-
Article ItemCampus librarian honored with two university awards , article
Roberto Silva, Fralin Biomedical Research Institute at VTC Health Sciences & Technology Library head, was honored with an Administrative and Professional Faculty Award and a Presidential Principles of Community Award.
We are committed to making our workplace inclusive for everyone. Read our Fralin Biomedical Research Institute Principles of Human Dignity and Non-Discrimination, and visit our Diversity and Inclusion page for more information.
Creating a healthier future. For everyone.
The Fralin Biomedical Research Institute at VTC is one of the nation’s fastest-growing academic biomedical research enterprises and a destination for world-class researchers. The institute’s Virginia Tech scientists focus on diseases that are the leading causes of death and suffering in the United States, including brain disorders, heart disease, and cancer. Since its founding in 2010, the research institute has experienced unprecedented growth: doubling its enterprise and lab facilities in Roanoke, while also investing in brand-new laboratories on the Children’s National Research & Innovation Campus in Washington, D.C.
NEWS
-
Article Item
-
Article Item
-
Article Item
In the News
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
VIDEOS
SEMINARS & EVENTS
-
Home ItemIn Person Event: Research in Progress Seminar , home
April 30, 4 to 5 p.m. | Samar Antar, Ph.D., and Xiaobo Wu, Ph.D. | Spring Research in Progress Seminar Series
-
Home ItemIn Person Seminar: Regulation of Mitochondrial Parameters in Skeletal Muscle , home
May 3, 2024, 11:00 a.m. | Glenn Rowe, Ph.D., Associate Professor of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home ItemDissertation Defense: Sodium Channel Loss of Function Sensitizes Conduction to Changes in Extracellular Sodium Concentration , home
May 6, 2024, 10 a.m. | William P. Adams | Graduate Student Dissertation Defense
-
Home ItemPlanning the Future of Environmental Health Sciences , home
May 9, 2024, 5:30 p.m. (Reception at 5 p.m.) | Rick Woychik, Ph.D., Director, National Institute of Environmental Health Sciences, National Institutes of Health | Maury Strauss Distinguished Public Lecture
-
Home ItemIn Person Seminar: Flavors in Tobacco and Nicotine Products: Science-based Regulation , home
May 10, 2024, 11:00 a.m. | Suchitra Krishnan-Sarin, Ph.D., Albert E. Kent Professor of Psychiatry, Yale School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and the Addiction Recovery Research Center
-
Home ItemFrom FBRI to NIH: Charting a Path Out of the Lab to Science Planning and Policy , home
May 14, 2024, 11 a.m. | Alicia Kerr, Ph.D., Health Science Policy Analyst, Office of Program Planning and Analysis, National Eye Institute, National Institutes of Health | Special Seminar
Giving to the Research Institute
Your generous support of the Fralin Biomedical Research Institute's rigorous biomedical research enterprise makes a difference for our faculty, students, and patients. Every donation helps accelerate the pace of new discoveries to help patients with cancer, neurological disorders, heart disease, and even rare genetic disorders. Private donations fast-track our progress.